CSF3 and acute myeloid leukemia: A low-dose chemotherapy (LDC) regimen featuring one-tenth of the standard dose of chemotherapeutic drug cytarabine and one-half of the dose of anthracycline in conjunction with granulocyte colony stimulating factor (G-CSF), was used in induction and consolidation therapies for elderly patients with AML who were medically unfit to receive intensive chemotherapy [17].